An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Federal Reports
Report Date
Agency Reviewed / Investigated
Report Title
Type
Location
U.S. Agency for International Development
Closeout Audit of the Schedule of Expenditures of USAID Award Managed by Ein Dor Museum Under Cooperative Agreement 72029418CA00003, Youth United Against Racism Program in West Bank and Gaza, January 1 to September 27, 2023
Independent Auditors’ Reports on the Tribal and Other Trust Funds and Individual Indian Monies Trust Funds Financial Statements for Fiscal Years 2025 and 2024
The Inspector General’s Assessment of the Most Serious Management and Performance Challenges Facing the U.S. Nuclear Regulatory Commission in Fiscal Year 2026
Audit of Schedule of Expenditures of EcoPeace Middle East Environmental NGO Forum, Partnership for Climate Resilience and Water Security Program in West Bank and Gaza, Cooperative Agreement 72029422CA00003, January 1 to December 31, 2023
This report highlights the accomplishments achieved through our oversight and investigative activities for the 6-month period ending September 30, 2025.
Review of Allegations Related to Nurse Practitioner Supervision and Controlled Substance Prescribing in Pain Management at the VA Central Texas Healthcare System in Temple
The VA Office of Inspector General (OIG) initiated a healthcare inspection at the VA Central Texas Healthcare System (system) in Temple to assess allegations that two pain management advanced practice registered nurses (pain management APRNs) were not appropriately supervised and were unqualified to prescribe controlled substances. The complainant also reported concerns regarding the potential for patient harm; however, the complainant was not aware of any patient safety events. The OIG did not substantiate the allegations and made no recommendations.
The OIG reviewed the pain management APRNs’ proficiency reports and practice evaluations from October 2022 through March 2025, did not identify any competency concerns, and found the supervisor completed the reports properly. The OIG also reviewed reports entered into the Veterans Health Administration’s (VHA’s) patient safety event reporting system during the same time frame and did not find any patient safety events related to the pain management APRNs.
The OIG reviewed the pain management APRNs’ credentialing and privileging documentation and found the APRNs had active Texas-issued registered nurse licenses and nurse practitioner certifications, Drug Enforcement Administration registrations, and system-approved clinical privileges with authorization to prescribe controlled substances. Further, the OIG did not identify any reported patient complaints or patient safety events.
The OIG concluded that the pain management APRNs’ service chief provided supervision as required by VHA and the APRNs were authorized and qualified to prescribe controlled substances.
